Evidence map›Paper›PMID 33028570›Full record

ArticleBMJ case reports2020

Hybrid dialysis: a promising strategy to reduce hospital access during the SARS-CoV-2 pandemic.

Giacomo Mori, Gaetano Alfano, Francesco Fontana, Riccardo Magistroni

Open access · greenAbstract readCase Reports
In one paragraph

Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Advances in Human-Centered Care to Address Contemporary Unmet Needs in Chronic Dialysis.International journal of nephrology and renovascular disease · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Giacomo MoriStruttura Complessa di Nefrologia Dialisi e Trapianto Renale, University Hospital Modena, Modena, Italy morigiacomo@hotmail.it.ORCID http://orcid.org/0000-0002-6668-2548
Gaetano AlfanoStruttura Complessa di Nefrologia Dialisi e Trapianto Renale, University Hospital Modena, Modena, Italy.
Francesco FontanaStruttura Complessa di Nefrologia Dialisi e Trapianto Renale, University Hospital Modena, Modena, Italy.
Riccardo MagistroniUniversità degli Studi di Modena e Reggio Emilia, Modena, Italy.ORCID http://orcid.org/0000-0002-3319-0248
Azienda Ospedaliero-Universitaria di Modena · ITUniversity of Modena and Reggio Emilia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In March 2020, a 74-year-old man affected by end-stage renal disease and on peritoneal dialysis was referred to an emergency room in Modena, Northern Italy, due to fever and respiratory symptoms. After ruling out COVID-19 infection, a diagnosis of chronic obstructive pulmonary disease exacerbation was confirmed and he was thus transferred to the nephrology division. Physical examination and blood tests revealed a positive fluid balance and insufficient correction of the uraemic syndrome, although peritoneal dialysis prescription was maximised. After discussion with the patient and his family, the staff decided to start hybrid dialysis, consisting of once-weekly in-hospital haemodialysis and home peritoneal dialysis for the remaining days. He was discharged at the end of the antibiotic course, after an internal jugular vein central venous catheter placement and the first haemodialysis session. This strategy allowed improvement of depuration parameters and avoidance of frequent access to the hospital, which is crucial in limiting exposure to SARS-CoV-2 in an endemic setting.

Indexed as

Coronavirus InfectionsKidney Failure, ChronicPandemicsPneumonia, ViralPulmonary Disease, Chronic ObstructiveAgedAnti-Bacterial AgentsBetacoronavirusCombined Modality TherapyCOVID-19Diagnosis, DifferentialHemodialysis Units, HospitalHumansInfection ControlMaleOrganizational InnovationAnti-Bacterial Agentsdialysisinfectious diseasesTB and other respiratory infections

Identifiers

PMID33028570
PMCPMC7542613
OpenAlexW3092311107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.